Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu USA Manufacturing Obtains ISO 13485 Certification

NEW YORK (GenomeWeb News) – Shimadzu USA Manufacturing said today it has obtained ISO 13485 certification for the manufacture of high performance liquid chromatographs and liquid chromatograph-mass spectrometry systems.

The certification allows Shimadzu USA Manufacturing to manufacture and supply analytical instruments for clinical testing in the US market, the company said, adding it will continue to register devices with the US Food and Drug Administration and support the growing demand for LC and LC-MS in the clinical testing space.

"Mass spectrometry has a growing presence in clinical research and laboratory medicine," Shinichi Matsunaga, president of Shimadzu USA Manufacturing, said in a statement. "Achieving ISO 13485 certification is a major milestone for Shimadzu and a great step towards developing mass spectrometry platforms as next-generation medical devices."

Shimadzu USA Manufacturing is the US manufacturing subsidiary of Shimadzu Corp., and is based in Canby, Ore.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.